In addition it addresses the FDA’s communications Together with the applicant, the retention of documents that assist the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of the SE report to a whole new applicant and electronic submission of your SE report